Second Generation B2K Inhibitors Look Promising ACP-196 & BGB-3111

Jennifer R. Brown, MD Director, Chronic Lymphocytic Leukemia Center Dana-Farber Cancer Institute discusses Second Generation B2K Inhibitors Look Promising ACP-196 & BGB-3111 at ASH 2015 Author: ASHReport Added: 12/10/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts